Ketan R. Patel

Ketan Patel is an Indian entrepreneur, pharmacist, chairman & managing director of Troikaa Pharmaceuticals, an Ahmedabad based multinational pharmaceutical company.[1]

Ketan Patel
Ketan Rajnibhai Patel
Born
Ahmedabad, Gujarat
NationalityIndian
Alma materL. M. College of Pharmacy, Dharamsinh Desai University
Occupationpharmacist, businessman

Education & career

Patel holds Gold Medals in Bachelor of Pharmacy and Master of Pharmacy from L. M. College of Pharmacy, Ahmedabad. He has a Ph.D. in Pharmaceutical Technology from Dharamsinh Desai University, Gujarat.[2]

Patel developed the “Rajnibhai.V. Patel Pharmlnnova Award” under the aegis of Department of Science and Technology (India).[3][4]

Patel is the Chairman of Board of Governors, NIPER, Ahmedabad[5] and Member of Academic Council, Gujarat Forensic Sciences University.[6] He is also the member of Board of Governors – Gujarat Technological University[7]

Invention

Patel is the primary inventor & patent holder of a painless diclofenac injection under the brand name – ‘DYNAPAR-AQ’ by Troikaa Pharmaceuticals Ltd. For this Government of India’s Department of Science & Industrial Research also conferred National Award in 2008.[8][9]

In 2008, he invented a quick penetrating solution of Diclofenac for topical administration known as 'DYNAPAR QPS', for which he was conferred National Award in 2015 by Department of Science & Technology, Govt of India.[10]

Publications
  • PENETRATION OF DICLOFENAC FROM NOVEL QUICK PENETRATING SOLUTION. A COMPARATIVE SCINTIGRAPHY STUDY WITH GEL, Sanjaykumar H. Maroo, Ketan R. Patel and Aseem Bhatnagar, International Journal of Pharma & Science Res.2013;5(4):175-178
  • A Comparative Dermal Microdialysis Study of Diclofenac QPS versus Conventional 1% Diclofenac Gel, Sanjay Kumar H. Maroo1*, Ketan R. Patel, Vipul Prajapati, Rajen Shah, Milind Bagul, ISSN 0975-248X, 2013, vol5, issue4
  • Comparison of Heparin Quick Penetrating Solution and Diclofenac Quick Penetrating Solution for the Prevention of Superficial Thrombophlebitis Caused by Peripheral Venous Cannulation: A Randomized Double-Blind Study, Akhileshwar and Swati Singh, doi: 10.4103/aer.AER_189_18, 2019 Jan-Mar; 13(1): 155–157, PMID 31031497
  • Evaluation of Skin Penetration of Diclofenac from a Novel Topical Non Aqueous Solution: A Comparative Bioavailability Study, Manish Nivsarkar, Sanjaykumar Maroo, Ketan R Patel, Dixit D Patel, ISSN: 0975-8232, 2017
gollark: There is not, as far as I know, an actual program like that, I made it up as a joke.
gollark: The Apple voice assistant thing?
gollark: Siri?
gollark: I think I actually have three different items with names like "47 command computers" now.
gollark: Hi.

References
  1. Talukdar, Tapash (8 September 2008). "The pain killer". The Economic Times.
  2. "L M COLLEGE OF PHARMACY M.PHARM. ALUMNI (1956-2013)" (PDF). lmcp.in.
  3. "Award" (PDF). .tnmgrmu.ac.in.
  4. "Home : PharmInnova Award". www.innovativethesisaward.org.
  5. "Ketanbhai Rajnibhai Patel vs State Of Gujarat on 4 September, 2019". indiankanoon.org.
  6. "Academic Council – Gujarat Forensic Sciences University". Gfsu.
  7. "Gujarat Technological University". www.gtu.ac.in.
  8. "Ketanbhai Rajnibhai Patel vs State Of Gujarat on 4 September, 2019". Indiankanoon.
  9. "Injectable preparations of diclofenic and its pharmaceutically acceptable salts". Patent Google. 30 January 2006.
  10. "A non-aqueous topical solution of diclofenac and process for preparing the same".
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.